Literature DB >> 6735759

Time-temperature relationship for hyperthermia induced stoppage of the microcirculation in tumors.

A E van den Berg-Block, H S Reinhold.   

Abstract

The time-temperature dependence for microcirculation stoppage was investigated for the Rhabdomyosarcoma BA1112 growing in observation chambers ("sandwich chambers"). The tumor microcirculation could be observed continuously during the treatment, and the condition of the microcirculation was recorded every 15 minutes as "flowing" or "stoppage". By using large numbers of tumors, the 50% stoppage time (ST50) could be derived for the four temperatures investigated: 42 degrees, 42.5 degrees, 43 degrees and 43.5 degrees C. The respective ST50 values were 226, 152, 101 and 70 minutes. The results can be expressed as a log-linear relationship with a slope value of 0.4551 +/- 0.03 (SD) per degree centigrade. This value probably does not differ significantly from the "t 1/2 for every degree C" rule that has been found for the thermal response of many biological systems.

Entities:  

Mesh:

Year:  1984        PMID: 6735759     DOI: 10.1016/0360-3016(84)90304-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  THERMAL DOSE REQUIREMENT FOR TISSUE EFFECT: EXPERIMENTAL AND CLINICAL FINDINGS.

Authors:  Mark W Dewhirst; Benjamin L Viglianti; Michael Lora-Michiels; P Jack Hoopes; Margaret Hanson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2003-06-02

Review 2.  Review of temperature dependence of thermal properties, dielectric properties, and perfusion of biological tissues at hyperthermic and ablation temperatures.

Authors:  Christian Rossmanna; Dieter Haemmerich
Journal:  Crit Rev Biomed Eng       Date:  2014

3.  Venules and arterioles in xenotransplanted human colon adenocarcinoma critically constrict with hyperthermia and serotonin.

Authors:  W Huhnt; A S Lübbe
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.